<DOC>
	<DOCNO>NCT00122837</DOCNO>
	<brief_summary>This clinical trial assess duloxetine comparator placebo patient generalize anxiety disorder .</brief_summary>
	<brief_title>A Comparison Duloxetine Hydrochloride , Marketed Comparator , Placebo Treatment Generalized Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Male female outpatient least 18 year age , present generalize anxiety disorder ( GAD ) . Any current primary Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSMIV ) Axis I diagnosis GAD . Patients diagnose major depressive disorder within past 6 month patient diagnose panic disorder , posttraumatic stress disorder , eat disorder within past year obsessivecompulsive disorder , bipolar affective disorder , psychosis factitious disorder , somatoform disorder lifetime The presence Axis II disorder history antisocial behavior , judgement investigator would interfere compliance study protocol Have previously complete withdrawn study study investigate duloxetine previously treat duloxetine History alcohol psychoactive substance abuse dependence ( defined DSMIVTR ) within past 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>